FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2193240541> ?p ?o ?g. }

• W2193240541 endingPage "2146" @default.
• W2193240541 startingPage "2141" @default.
• W2193240541 abstract "Clinical guidelines recommend norepinephrine as initial vasopressor of choice for septic shock, with dopamine suggested as an alternative vasopressor in selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia. We sought to determine practice patterns and outcomes associated with vasopressor selection in a large, population-based cohort of patients with septic shock that allows for assessment of outcomes in clinically important subgroups.We performed a retrospective cohort study to determine factors associated with choice of dopamine as compared with norepinephrine as initial vasopressor for patients with septic shock. We used propensity score matching to compare risk of hospital mortality based on initial vasopressor. We performed multiple sensitivity analyses using alternative methods to address confounding and hospital-level clustering. We investigated interaction between vasopressor selection and mortality in clinical subgroups based on arrhythmia and cardiovascular risk.Enhanced administrative data (Premier, Charlotte, NC) from 502 U.S. hospitals during the years 2010-2013.A total of 61,122 patients admitted with septic shock who received dopamine or norepinephrine as initial vasopressor during the first 2 days of hospitalization.None.Norepinephrine (77.6%) was the most frequently used initial vasopressor during septic shock. Dopamine was preferentially selected by cardiologists, in the Southern United States, at nonteaching hospitals, for older patients with more cardiovascular comorbidities and was used less frequently over time. Patients receiving dopamine experienced greater hospital mortality (propensity-matched cohort: n = 38,788; 25% vs 23.7%; odds ratio, 1.08; 95% CI, 1.02-1.14). Sensitivity analyses showed similar results. Subgroup analyses showed no evidence for effect modification based on arrhythmia risk or underlying cardiovascular disease.In a large population-based sample of patients with septic shock in the United States, use of dopamine as initial vasopressor was associated with increased mortality among multiple clinical subgroups. Areas where use of dopamine as initial vasopressor is more common represent potential targets for quality improvement intervention." @default.
• W2193240541 created "2016-06-24" @default.
• W2193240541 creator A5000221548 @default.
• W2193240541 creator A5015841346 @default.
• W2193240541 creator A5067804156 @default.
• W2193240541 date "2015-10-01" @default.
• W2193240541 modified "2023-09-26" @default.
• W2193240541 title "Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock*" @default.
• W2193240541 cites W1988984458 @default.
• W2193240541 cites W2002961373 @default.
• W2193240541 cites W2012487908 @default.
• W2193240541 cites W2015329932 @default.
• W2193240541 cites W2027831139 @default.
• W2193240541 cites W2029411057 @default.
• W2193240541 cites W2029949452 @default.
• W2193240541 cites W2042672404 @default.
• W2193240541 cites W2049927822 @default.
• W2193240541 cites W2061326496 @default.
• W2193240541 cites W2095944485 @default.
• W2193240541 cites W2104415072 @default.
• W2193240541 cites W2145577370 @default.
• W2193240541 cites W2148422817 @default.
• W2193240541 cites W2150291618 @default.
• W2193240541 cites W2172111103 @default.
• W2193240541 cites W2331591468 @default.
• W2193240541 cites W2442246762 @default.
• W2193240541 doi "https://doi.org/10.1097/ccm.0000000000001149" @default.
• W2193240541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5094367" @default.
• W2193240541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26079345" @default.
• W2193240541 hasPublicationYear "2015" @default.
• W2193240541 type Work @default.
• W2193240541 sameAs 2193240541 @default.
• W2193240541 citedByCount "13" @default.
• W2193240541 countsByYear W21932405412015 @default.
• W2193240541 countsByYear W21932405412016 @default.
• W2193240541 countsByYear W21932405412017 @default.
• W2193240541 countsByYear W21932405412018 @default.
• W2193240541 countsByYear W21932405412019 @default.
• W2193240541 countsByYear W21932405412020 @default.
• W2193240541 countsByYear W21932405412021 @default.
• W2193240541 countsByYear W21932405412022 @default.
• W2193240541 crossrefType "journal-article" @default.
• W2193240541 hasAuthorship W2193240541A5000221548 @default.
• W2193240541 hasAuthorship W2193240541A5015841346 @default.
• W2193240541 hasAuthorship W2193240541A5067804156 @default.
• W2193240541 hasBestOaLocation W21932405412 @default.
• W2193240541 hasConcept C126322002 @default.
• W2193240541 hasConcept C156957248 @default.
• W2193240541 hasConcept C167135981 @default.
• W2193240541 hasConcept C177713679 @default.
• W2193240541 hasConcept C17923572 @default.
• W2193240541 hasConcept C194828623 @default.
• W2193240541 hasConcept C201903717 @default.
• W2193240541 hasConcept C2777628635 @default.
• W2193240541 hasConcept C2778384902 @default.
• W2193240541 hasConcept C2778514916 @default.
• W2193240541 hasConcept C2781300812 @default.
• W2193240541 hasConcept C2908647359 @default.
• W2193240541 hasConcept C42219234 @default.
• W2193240541 hasConcept C513476851 @default.
• W2193240541 hasConcept C71924100 @default.
• W2193240541 hasConcept C72563966 @default.
• W2193240541 hasConcept C77350462 @default.
• W2193240541 hasConcept C99454951 @default.
• W2193240541 hasConceptScore W2193240541C126322002 @default.
• W2193240541 hasConceptScore W2193240541C156957248 @default.
• W2193240541 hasConceptScore W2193240541C167135981 @default.
• W2193240541 hasConceptScore W2193240541C177713679 @default.
• W2193240541 hasConceptScore W2193240541C17923572 @default.
• W2193240541 hasConceptScore W2193240541C194828623 @default.
• W2193240541 hasConceptScore W2193240541C201903717 @default.
• W2193240541 hasConceptScore W2193240541C2777628635 @default.
• W2193240541 hasConceptScore W2193240541C2778384902 @default.
• W2193240541 hasConceptScore W2193240541C2778514916 @default.
• W2193240541 hasConceptScore W2193240541C2781300812 @default.
• W2193240541 hasConceptScore W2193240541C2908647359 @default.
• W2193240541 hasConceptScore W2193240541C42219234 @default.
• W2193240541 hasConceptScore W2193240541C513476851 @default.
• W2193240541 hasConceptScore W2193240541C71924100 @default.
• W2193240541 hasConceptScore W2193240541C72563966 @default.
• W2193240541 hasConceptScore W2193240541C77350462 @default.
• W2193240541 hasConceptScore W2193240541C99454951 @default.
• W2193240541 hasIssue "10" @default.
• W2193240541 hasLocation W21932405411 @default.
• W2193240541 hasLocation W21932405412 @default.
• W2193240541 hasLocation W21932405413 @default.
• W2193240541 hasLocation W21932405414 @default.
• W2193240541 hasOpenAccess W2193240541 @default.
• W2193240541 hasPrimaryLocation W21932405411 @default.
• W2193240541 hasRelatedWork W1984304831 @default.
• W2193240541 hasRelatedWork W2015975988 @default.
• W2193240541 hasRelatedWork W2019121236 @default.
• W2193240541 hasRelatedWork W2141522520 @default.
• W2193240541 hasRelatedWork W2202905947 @default.
• W2193240541 hasRelatedWork W2406430194 @default.
• W2193240541 hasRelatedWork W2994793273 @default.
• W2193240541 hasRelatedWork W2997146678 @default.
• W2193240541 hasRelatedWork W3025110062 @default.

• next